Moderna (MRNA) Tops Q4 EPS by $1.39, Announces $3 billion share repurchase plan

Moderna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.

• Moderna announces a new $3 billion share repurchase plan

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• MP Materials seen largely insulated after China export-control move